Mochida Pharmaceutical Co., Ltd. (FRA:MFY)

Mochida Pharmaceutical Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	49,721	45,154	33,290	47,010	48,415	54,487
Short-Term Investments	2,996	5,996	13,499	13,499	13,499	8,999
Cash & Short-Term Investments	52,717	51,150	46,789	60,509	61,914	63,486
Cash Growth	0.05%	9.32%	-22.67%	-2.27%	-2.48%	3.58%
Receivables	32,901	31,617	34,838	27,806	31,676	29,189
Inventory	33,815	33,295	30,278	24,404	23,127	22,605
Other Current Assets	3,942	3,607	4,757	4,660	4,731	3,513
Total Current Assets	123,375	119,669	116,662	117,379	121,448	118,793
Property, Plant & Equipment	15,890	15,940	15,874	15,049	14,528	13,299
Long-Term Investments	24,298	21,740	23,169	21,722	22,758	25,853
Other Intangible Assets	1,136	920	721	797	713	646
Long-Term Deferred Tax Assets	1,020	1,851	2,372	3,883	3,691	3,198
Other Long-Term Assets	2	1	2	1	1	2
Total Assets	165,721	160,121	158,800	158,831	163,139	161,791
Accounts Payable	10,998	8,660	12,182	9,957	11,899	9,722
Accrued Expenses	2,081	2,357	2,178	2,374	2,711	2,536
Current Income Taxes Payable	1,561	1,510	593	501	1,652	2,061
Other Current Liabilities	11,456	12,375	11,120	14,426	13,594	14,391
Total Current Liabilities	26,096	24,902	26,073	27,258	29,856	28,710
Pension & Post-Retirement Benefits	3,598	3,690	3,908	4,133	4,270	4,652
Other Long-Term Liabilities	821	835	853	666	367	1,455
Total Liabilities	30,515	29,427	30,834	32,057	34,493	34,817
Common Stock	7,229	7,229	7,229	7,229	7,229	7,229
Additional Paid-In Capital	1,871	1,871	1,871	1,871	1,871	1,871
Retained Earnings	118,553	116,114	117,022	118,943	121,668	116,288
Treasury Stock	-3,268	-3,267	-7,021	-7,114	-9,617	-8,857
Comprehensive Income & Other	10,821	8,747	8,865	5,845	7,495	10,443
Shareholders' Equity	135,206	130,694	127,966	126,774	128,646	126,974
Total Liabilities & Equity	165,721	160,121	158,800	158,831	163,139	161,791
Net Cash (Debt)	52,717	51,150	46,789	60,509	61,914	63,486
Net Cash Growth	0.05%	9.32%	-22.67%	-2.27%	-2.48%	3.58%
Net Cash Per Share	1487.06	1442.84	1304.66	1628.34	1624.95	1643.31
Filing Date Shares Outstanding	35.45	35.45	35.45	36.53	37.57	38.27
Total Common Shares Outstanding	35.45	35.45	35.45	36.53	37.57	38.27
Working Capital	97,279	94,767	90,589	90,121	91,592	90,083
Book Value Per Share	3813.97	3686.66	3609.61	3470.15	3424.20	3317.90
Tangible Book Value	134,070	129,774	127,245	125,977	127,933	126,328
Tangible Book Value Per Share	3781.92	3660.71	3589.27	3448.33	3405.23	3301.02

Source: S&P Global Market Intelligence. Standard template. Financial Sources.